Gene Solutions Expands into Türkiye with AI-Powered Cancer Detection
Gene Solutions has announced its strategic entry into the Turkish market at the 2nd International Hereditary Cancers Congress (IHCC), held February 5–8, 2026, in Antalya, announced in a press release. The event gathered over 600 oncology and genetics experts to discuss evidence-based hereditary cancer care.
In partnership with ATC Genomics, the company presented one of Asia’s largest real-world datasets for AI-powered multi-cancer early detection. It also showcased its clinically validated ctDNA-based oncology portfolio designed for high-risk and hereditary populations.
Gene Solutions stated that the initiative aims to support localized and scalable implementation of genomic medicine in Türkiye, with a focus on improving outcomes for patients with hereditary and high-risk cancers.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Astrin Names Medical Director as Certitude Breast Expands Nationwide
MediSights Reports Study Using AI Agents for Myeloma Market Research
Aignostics Opens Early Access to PathoSearch
MGI Tech Launches VisiOmics in Europe
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Daily AI Brief: the AI news that matters, in your inbox.